SARS-CoV-2 Pseudoviral Particles, D614G
|
Catalog Number:
SCV2-PsV-614G
|
|
SARS-CoV-2 Pseudoviral Particles, replication-deficient MLV pseudotyped with the SARS-CoV-2 spike protein (the 614G variant). (Mobile users please click "View Full Site" for details)
|
Detailed Description
Keyword: coronavirus, SARS, SARS-Cov, SARS-COV-2, covid19, covid-19, SARS pseudovirus, sars-cov-2 pseudovirus, sars-cov-2 spike, MLV, ace2, D614G, 614G
|
SCV2-PsV-614G
|
|
Name
|
SARS-CoV-2 Pseudoviral Particles, D614G
|
|
Description
|
The SARS-CoV-2 Pseudoviral Particles are replication-deficient Maloneymurine leukemia virus (MLV or MuLV) pseudotyped with the SARS-CoV-2 spike protein carrying the 614G genotype (Genbank Accession # QHD43416.1, p.614D-->G).
MLV-based virus system is a better choice than HIV-based lentivirus system for making pseudoviral particles in regards of lab safety and product quality. Gag-Pol is the only component from MLV.
|
|
Applications
|
Our Pseudovirus Particles generate robust chemiluminescent signals in cell assays when coupled with our firefly luciferase assay kit (Catalog # CA-L165), useful for 1) screening potential inhibitors to block SARS-CoV-2 entry and viral protein; 2) measuring the activity of and screening for neutralizing antibody against SARS-CoV-2.
|
|
Size
|
5 ml, for one multi-well plate. Pseudoviral particles per mL ~ 1.0E+08
|
|
Storage
|
-70oC. Shipped on dry ice.
|
|
Note
|
1. Amenable to HTS format (96-well, 384-well and 1536-well format).
2. HEK293-hACE2 stable cells are available seperately (Cat..# CL-hACE2-001, CL-hACE2-002)
|
|
For Downloading
|
===> DATA SHEET ===> SAFETY DATA SHEET
|
Reference: Tracking Changes in SARS-Cov-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus, Korber et al., 2020, Cell 182, 1–16.
For the updates on this D614G variation, please the Questions & Answers researchers have compiled.
|
|
|